SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-05-000465
Filing Date
2005-01-04
Accepted
2005-01-04 09:28:57
Documents
1
Period of Report
2005-01-03

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP rrd63394.html 4  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP rrd63394.xml 4 3520
  Complete submission text file 0001181431-05-000465.txt   5603
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O ANTARES PHARMA, INC. 707 EAGLEVIEW BOULEVARD, SUITE 414 EXTON PA 19341
Business Address 610-458-6200
Wotton Paul K (Reporting) CIK: 0001300997 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 05504123